Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

LPCN

+ Watchlist+ Portfolio

Lipocine Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$1.60
52-Week Range
$1.36 – $12.37
Market Cap
$16.83M
P/E (TTM)
—
EPS (TTM)
-1.32
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.59
PEG Ratio
—
Return on Equity
-52.86%
Return on Assets
-32.07%
Gross Margin
100.00%
Operating Margin
-269.06%
Profit Margin
-249.16%
Current Ratio
11.36
Debt/Equity
0.01
Total Debt
$161.13K
Free Cash Flow
$-6.75M
Revenue Growth
1898.80%
Earnings Growth
—
Enterprise Value
$-4.46M

Market Snapshot

About

Lipocine Inc. is a specialty pharmaceutical company focused on developing innovative pharmaceutical products for metabolic and endocrine disorders. The company uses proprietary drug delivery technologies to create oral formulations of therapies traditionally delivered by injection. Lipocine targets conditions including hypogonadism, liver disease, and metabolic dysfunction.